Eyeguide, Inc.

SEWELL, NJ · Medtech · Private

10-second eye-tracking test that measures eye movements to assess brain health and cognitive function

Claim this profile

Follows are private to you and power your alerts

Updated · eyeguide.tech

Sector
Medtech
Headquarters
SEWELL, NJ
Latest Form D
$50K, Jul 2023
Total capital
$875K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$875K
3 Form D · last Jul 2023
40 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2019
Rank in peer group#55 of 160

Capital timeline

201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $875K1st Form D$800K2nd Form D$25K3rd Form D$50K
201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $875K1st Form D$800K2nd Form D$25K3rd Form D$50K

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$50K
  • Private capital raisedForm D · SEC · 2nd filing$25K
  • Private capital raisedForm D · SEC · 1st filing$800K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#55 · top 34%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Albert CharpentierDirectorNamed in SEC Form D filings
  • Ashesh J. ShahDirectorNamed in SEC Form D filings
  • Brian StillDirectorNamed in SEC Form D filings
  • Geoffrey GardnerDirectorNamed in SEC Form D filings
  • Greg J. GamelExecutive Officer, DirectorNamed in SEC Form D filings
  • James MackeyDirectorNamed in SEC Form D filings
Show all 11 people
  • Jerry J. WebbDirectorNamed in SEC Form D filings
  • Joel J. PinaDirectorNamed in SEC Form D filings
  • Joyce J. CarterExecutive Officer, DirectorNamed in SEC Form D filings
  • Patrick J. CarneyExecutive Officer, DirectorNamed in SEC Form D filings
  • Ronny J. WallDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .